These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease. Zheng R; Jin CY; Chen Y; Ruan Y; Gao T; Lin ZH; Dong JX; Yan YP; Tian J; Pu JL; Zhang BR Mol Genet Genomic Med; 2020 Oct; 8(10):e1449. PubMed ID: 32794657 [TBL] [Abstract][Full Text] [Related]
7. Identification of sixteen novel candidate genes for late onset Parkinson's disease. Gialluisi A; Reccia MG; Modugno N; Nutile T; Lombardi A; Di Giovannantonio LG; Pietracupa S; Ruggiero D; Scala S; Gambardella S; ; Iacoviello L; Gianfrancesco F; Acampora D; D'Esposito M; Simeone A; Ciullo M; Esposito T Mol Neurodegener; 2021 Jun; 16(1):35. PubMed ID: 34148545 [TBL] [Abstract][Full Text] [Related]
8. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort. Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256 [TBL] [Abstract][Full Text] [Related]
9. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ; Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347 [TBL] [Abstract][Full Text] [Related]
10. Analysis of genetic risk factors in Japanese patients with Parkinson's disease. Kanaya Y; Kume K; Morino H; Ohsawa R; Kurashige T; Kamada M; Torii T; Izumi Y; Maruyama H; Kawakami H J Hum Genet; 2021 Oct; 66(10):957-964. PubMed ID: 33742109 [TBL] [Abstract][Full Text] [Related]
11. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
12. The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review. Koros C; Bougea A; Simitsi AM; Papagiannakis N; Angelopoulou E; Pachi I; Antonelou R; Bozi M; Stamelou M; Stefanis L Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003040 [TBL] [Abstract][Full Text] [Related]
13. Novel and reported variants in Parkinson's disease genes confer high disease burden among Indians. Kumar S; Yadav N; Pandey S; Muthane UB; Govindappa ST; Abbas MM; Behari M; Thelma BK Parkinsonism Relat Disord; 2020 Sep; 78():46-52. PubMed ID: 32707456 [TBL] [Abstract][Full Text] [Related]
14. No association of DNM3 with age of onset in Asian Parkinson's disease. Foo JN; Tan LC; Au WL; Prakash KM; Liu J; Tan EK Eur J Neurol; 2019 May; 26(5):827-829. PubMed ID: 30133089 [TBL] [Abstract][Full Text] [Related]
15. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey. Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340 [TBL] [Abstract][Full Text] [Related]
16. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease. Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865 [TBL] [Abstract][Full Text] [Related]
17. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study. Westenberger A; Skrahina V; Usnich T; Beetz C; Vollstedt EJ; Laabs BH; Paul JJ; Curado F; Skobalj S; Gaber H; Olmedillas M; Bogdanovic X; Ameziane N; Schell N; Aasly JO; Afshari M; Agarwal P; Aldred J; Alonso-Frech F; Anderson R; Araújo R; Arkadir D; Avenali M; Balal M; Benizri S; Bette S; Bhatia P; Bonello M; Braga-Neto P; Brauneis S; Cardoso FEC; Cavallieri F; Classen J; Cohen L; Coletta D; Crosiers D; Cullufi P; Dashtipour K; Demirkiran M; de Carvalho Aguiar P; De Rosa A; Djaldetti R; Dogu O; Dos Santos Ghilardi MG; Eggers C; Elibol B; Ellenbogen A; Ertan S; Fabiani G; Falkenburger BH; Farrow S; Fay-Karmon T; Ferencz GJ; Fonoff ET; Fragoso YD; Genç G; Gorospe A; Grandas F; Gruber D; Gudesblatt M; Gurevich T; Hagenah J; Hanagasi HA; Hassin-Baer S; Hauser RA; Hernández-Vara J; Herting B; Hinson VK; Hogg E; Hu MT; Hummelgen E; Hussey K; Infante J; Isaacson SH; Jauma S; Koleva-Alazeh N; Kuhlenbäumer G; Kühn A; Litvan I; López-Manzanares L; Luxmore M; Manandhar S; Marcaud V; Markopoulou K; Marras C; McKenzie M; Matarazzo M; Merello M; Mollenhauer B; Morgan JC; Mullin S; Musacchio T; Myers B; Negrotti A; Nieves A; Nitsan Z; Oskooilar N; Öztop-Çakmak Ö; Pal G; Pavese N; Percesepe A; Piccoli T; Pinto de Souza C; Prell T; Pulera M; Raw J; Reetz K; Reiner J; Rosenberg D; Ruiz-Lopez M; Ruiz Martinez J; Sammler E; Santos-Lobato BL; Saunders-Pullman R; Schlesinger I; Schofield CM; Schumacher-Schuh AF; Scott B; Sesar Á; Shafer SJ; Sheridan R; Silverdale M; Sophia R; Spitz M; Stathis P; Stocchi F; Tagliati M; Tai YF; Terwecoren A; Thonke S; Tönges L; Toschi G; Tumas V; Urban PP; Vacca L; Vandenberghe W; Valente EM; Valzania F; Vela-Desojo L; Weill C; Weise D; Wojcieszek J; Wolz M; Yahalom G; Yalcin-Cakmakli G; Zittel S; Zlotnik Y; Kandaswamy KK; Balck A; Hanssen H; Borsche M; Lange LM; Csoti I; Lohmann K; Kasten M; Brüggemann N; Rolfs A; Klein C; Bauer P Brain; 2024 Aug; 147(8):2652-2667. PubMed ID: 39087914 [TBL] [Abstract][Full Text] [Related]
18. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients. Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292 [TBL] [Abstract][Full Text] [Related]
19. Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease. Rizig M; Ojo OO; Athanasiou-Fragkouli A; Agabi OP; Oshinaike OO; Houlden H; Okubadejo NU Neurobiol Aging; 2021 Mar; 99():101.e15-101.e19. PubMed ID: 33158606 [TBL] [Abstract][Full Text] [Related]
20. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]